Paraproteinemias
Showing 26 - 50 of 95
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Recruiting
- Multiple Myeloma
- +11 more
- No intervention
-
Beijing, ChinaPeking University First Hospital
Apr 21, 2022
Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Multiple Myeloma
- Metformin XR
- Placebo
-
Boston, Massachusetts
- +6 more
Oct 3, 2022
Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life
Active, not recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Clinical follow-up 1
- +5 more
-
Reykjavík, IcelandUniversity of Iceland
Feb 28, 2022
IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)
Recruiting
- IgA Monoclonal Gammopathy
- +8 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 18, 2021
Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill
Recruiting
- Multiple Myeloma
- +8 more
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital
Nov 30, 2021
Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)
Not yet recruiting
- Monoclonal Gammopathy
- +2 more
- DKK1
-
Cleveland, Ohio
- +1 more
Nov 29, 2021
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,
Completed
- Myelodysplastic Syndrome
- +13 more
- Fludarabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
Aplastic Anemia, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Ibrutinib)
Active, not recruiting
- Aplastic Anemia
- +6 more
- Best Practice
- Ibrutinib
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 24, 2022
Progression to Myeloma in Asymptomatic Monoclonal Gammopathies
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Plasma Cell Myeloma
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 4, 2021
Natural History of MGUS in Patients Undergoing Weight Reduction
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
-
Indianapolis, IndianaIndiana University Simon Cancer Center
Jun 23, 2021
MGUS, SMM, and MM Patient Experience With Coronavirus 19 Survey
Recruiting
- Multiple Myeloma
- +3 more
- Questionnaire
-
Lehi, UtahHealthTree.org (Online)
Aug 2, 2021
Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee
Enrolling by invitation
- Monoclonal Gammopathy of Undetermined Significance
- +6 more
-
Milwaukee, WisconsinAurora Health Care
Jul 20, 2021
Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Whole Foods Plant-based Diet
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Multiple Myeloma
- Plant based meals
-
Basking Ridge, New Jersey
- +6 more
Apr 11, 2022
4TS RAM in Prevention of Venous Thromboembolism in Plasma Cell
Recruiting
- Multiple Myeloma
- Venous Thromboembolism
- No intervention
-
Athens, Attica, GreeceAlexandra Hospital , Department of Clinical Therapeutics
Apr 27, 2021
AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing
Enrolling by invitation
- AL Amyloidosis
- Plasma Cell Dyscrasia
-
Nanjing, Jiangsu, ChinaNational Clinical Research Center of Kidney Diseases, Jinling Ho
Jan 26, 2021
Monoclonal Gammopathy, Smoldering Multiple Myeloma Trial in United States (Daratumumab)
Active, not recruiting
- Monoclonal Gammopathy
- Smoldering Multiple Myeloma
-
Monterey, California
- +5 more
Nov 1, 2021
MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular
Recruiting
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- +8 more
-
Boston, Massachusetts
- +6 more
Apr 14, 2022
Monoclonal Gammopathy of Undetermined Significance and
Terminated
- Smoldering Myeloma
- Monoclonal Gammopathy of Undetermined Significance
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 4, 2021
Genomic, Transcriptomic and Functional Characteristics of Tumor
Not yet recruiting
- Monoclonal Gammopathy of Undetermined Significance
- +2 more
-
Paris, FranceService de Médecine Interne
Jan 8, 2021
The Development and Pilot Testing ofNew MR Imaging Protocol to
Completed
- Myeloma
- +2 more
- Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
- +2 more
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Feb 4, 2021
Pruritus in Patients With Monoclonal Gammopathy
Completed
- Pruritus
- Monoclonal Gammopathy
-
Brest, FranceCHRU de Brest
Aug 25, 2020
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023